These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32538071)

  • 1. Metabolism and Toxicity of Emodin: Genome-Wide Association Studies Reveal Hepatocyte Nuclear Factor 4α Regulates UGT2B7 and Emodin Glucuronidation.
    Chen Y; Zhang T; Wu L; Huang Y; Mao Z; Zhan Z; Chen W; Dai F; Cao W; Cao Y; Liu S; Cai Z; Tang L
    Chem Res Toxicol; 2020 Jul; 33(7):1798-1808. PubMed ID: 32538071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Hepatotoxicity and Toxicokinetics of Emodin: The Potential Mechanisms Mediated by UGT2B7 and MRP2.
    Wu L; Han W; Chen Y; Zhang T; Liu J; Zhong S; Liu H; Han C; Zhang Z; Liu S; Tang L
    Mol Pharm; 2018 Sep; 15(9):3931-3945. PubMed ID: 30011215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
    Wang H; Yuan L; Zeng S
    Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
    Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
    Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
    Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
    Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
    Yuan L; Qian S; Xiao Y; Sun H; Zeng S
    Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
    Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
    Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
    Ishii Y; Hansen AJ; Mackenzie PI
    Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
    Margaillan G; Rouleau M; Fallon JK; Caron P; Villeneuve L; Turcotte V; Smith PC; Joy MS; Guillemette C
    Drug Metab Dispos; 2015 Apr; 43(4):611-9. PubMed ID: 25650382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
    Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A
    Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes.
    Fujiwara R; Nakajima M; Oda S; Yamanaka H; Ikushiro S; Sakaki T; Yokoi T
    J Pharm Sci; 2010 Jan; 99(1):442-54. PubMed ID: 19475557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells.
    Zhang T; Dong D; Lu D; Wang S; Wu B
    Int J Pharm; 2016 Mar; 501(1-2):190-8. PubMed ID: 26850314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human UDP-glucuronosyltransferase 2B7.
    Radominska-Pandya A; Little JM; Czernik PJ
    Curr Drug Metab; 2001 Sep; 2(3):283-98. PubMed ID: 11513331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4.
    Takeda S; Ishii Y; Iwanaga M; Mackenzie PI; Nagata K; Yamazoe Y; Oguri K; Yamada H
    Mol Pharmacol; 2005 Mar; 67(3):665-72. PubMed ID: 15611481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N
    Ondo K; Isono M; Nakano M; Hashiba S; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Jul; 189():114402. PubMed ID: 33387482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.